Associated Press Published

Mylan CEO Infuriates Lawmakers at Hearing on EpiPen Costs

Mylan CEO Heather Bresch holds up an EpiPen while testifying on Capitol Hill in Washington, Wednesday, Sept. 21, 2016, before the House Oversight Committee hearing on EpiPen price increases.

Mylan CEO Heather Bresch infuriated lawmakers as she tried to explain steep cost increases of her company’s life-saving EpiPens.

Outraged Republican and Democratic lawmakers on Wednesday grilled Bresch about the emergency allergy shot’s sky-high price and the profits for a company with sales in excess of $11 billion. The list price of EpiPens has grown to $608 for a two-pack, an increase of more than 500 percent since 2007.

In almost four hours of questioning, the soft-spoken CEO at times seemed unsure when asked questions about the company’s finances and profits, angering lawmakers.

House Oversight and Government Reform Chairman Rep. Jason Chaffetz of Utah said he didn’t believe Bresch was being candid with lawmakers.

Bresch said she wishes Mylan had “better anticipated the magnitude and acceleration” of rising prices.

Bresch is the daughter of West Virginia’s Democratic Sen. Joe Manchin. Mylan Pharmaceuticals has a large operation in Morgantown, W.Va.